Cell Analysis Market : Global Industry Analysis and Forecast 2023-2029

The cell analysis market is expected to grow from USD 18 Billion in 2022 to USD 36.20 Billion by 2029; it is expected to grow at a CAGR of 10.5% during the forecast period.

Cell-based diagnostics give a lot of information in fundamental research, drug discovery and development, and clinical applications. Cell analysis is important for understanding, predicting, and eventually analyzing factors through the use of numerous technologies such as PCR, Sequencing, Microfluidics, Spectrometry, Microscopes, High content analysis, and others. All of these methods are important in analyzing gene, protein, and RNA expression in cells for study, diagnosis, and treatment development. The total number of cancer deaths was estimated to be approximately 9.58 million in 2020. Around one-fifth of these deaths were in Europe. Cell diagnostics have become an important tool for healthcare practitioners for the investigations necessary in providing better treatment for a disease like cancer. Increased investment in cell-based research activities, growing acceptance of cell-based diagnostics in drug discovery, and an increase in the number of drug discovery activities all contribute to the growth of the cell analysis market.To know about the Research Methodology :- Request Free Sample Report

Reduced time and expense associated with drug discovery procedures are made possible by the improved accuracy of cell imaging and analysis systems. Today, thousands of cells are examined in each sample during mass cell analysis, and results are evaluated based on the average response of the cells. Emerging Asian economies offer profitable opportunities for market growth with low costs associated with raw materials. Several government authorities in the Asia Pacific region are focusing on life science research, specifically post the outbreak of the COVID-19 pandemic. The sudden outbreak of the COVID-19 pandemic has led to the adoption of cell analysis technology in research procedures for developing effective vaccines, drugs, and testing kits to combat the risk of coronavirus infection. For instance, the Global Health Innovative Technology Fund is a public-private partnership in Japan that invests in several R&D activities for drug discovery, which also includes the screening of compound libraries related to various infectious diseases. R&D spending for new drug development is a critical growth driver for the global cell analysis industry.
Competitive Landscape
The market for cell analysis is moderately competitive and consists of local as well as global players. Developing countries are having a large number of local players that are catering to consumers across laboratories. However, the largest share of the market on the global scale is grabbed by international companies such as Thermo Fisher Scientific, Sartorius AG, Danaher Corporation, etc. It is believed that there will be an emergence of new market players in the future With the advancements in the biotech industry.
Cell Analysis Market Dynamics:
Increasing Prevalence of Chronic Deceases and Cancer to Boost Cell Analysis market

The global burden of cancer, as well as the rising biotech sector and research in cell biology, are driving the growth of the cell analysis equipment market. Cancer is one of the most common causes of death worldwide, accounting for approximately one out of every six deaths in 2020. The disease has grown significantly in the previous several decades and is expected to grow significantly in the next years. According to the National Cancer Institute, about 1,745,350 cases of cancer were discovered in the United States in 2020. Furthermore, the World Health Organization predicts that cancer fatalities would rise by 70% over the next two decades globally. Biotech research companies and universities have shown a strong interest in single-cell DNA and RNA quantification methods in recent years. As a result, all of these reasons are raising the need for cell analysis equipment during the forecast period.

Microfluidics in Single-Cell Analysis

Microfluidic single-cell analysis has been widely used in numerous applications, including intracellular signaling, myocyte contraction, drug discovery, patch-clamp recording, multidrug resistance, genetic analysis, protein analysis, and so on. Among those applications, particularly, considering that cancer cells show high levels of cellular heterogeneity and microfluidic single-cell analysis plays a more and more important role in cancer research and anticancer drug discovery. Single-cell analyses of all types are increasingly being used to tackle a wide range of biological issues, and as their use grows, potential drawbacks to these methods become more evident. Microfluidic technology has emerged as a significant tool for analyzing single cells, with the ability to integrate time-consuming and labor-intensive experimental techniques such as single-cell capture into a single microdevice with ease and in a high-throughput mode. Single-cell manipulation and analysis may be carried out within a multi-functional microfluidic device for a variety of cancer research applications.Emerging Asian economies provide an attractive potential for market growth with low costs for raw materials.

Several governments in the Asia Pacific area are also concentrating on life science research, particularly in the wake of the COVID-19 epidemic. For instance, a public-private collaboration in Japan called the Global Health Innovative Technology (GHIT) Fund supports a range of R&D initiatives for drug discovery, including the screening of compound libraries relevant to numerous infectious diseases. The global cell analysis assay market is primarily driven by R&D spending for the development of novel drugs.

Cell-based assays are becoming more used in drug discovery.

Traditional methods of drug safety assessment that include animal testing techniques are expensive, have limited throughput, and take a long time. The most recent cell-based assays combine the benefits of animal models with cell cultures, allowing researchers to improve the efficacy of lead detection in early screening. Furthermore, the capacity of cell-based assays to deliver cost-effective and accelerated drug discovery options has fueled the market growth.Market Restraint

High content screening (HCS), one of the sophisticated cell analysis technologies, has increased the price of instruments. The complexity of the targeted molecule also has an immediate impact on each HTS method' cost and time. Therefore, novel cell analysis solutions are only available to a select number of end consumers. For instance, whereas universities and research laboratories struggle to purchase such expensive devices due to funding constraints, pharmaceutical and biopharmaceutical corporations are at the forefront of the market. This limits the adoption of cell analysis products generally to some level, which restrains the market's growth. However, some challenges are somewhat limiting the growth of the cell analysis market.

These include strict regulatory requirements, a lack of experienced specialists, and the high cost of image analysis equipment. Traditional genomic research techniques that use DNA and RNA fragments may be dangerous for the cell analysis market. The majority of workflows in the genomics field currently rely on traditional approaches to gene analysis. Growth of the market may be hampered by the presence of companies like F. Hoffmann-La Roche Ltd. and Illumina, Incwhichat provides advanced sequencing technologies for genomics workflows based on DNA & resamples.
Cell Analysis Market Segment Analysis:
By Product & Service, the consumables segment dominated the market and accounted for the highest revenue share of 59.1 % in 2022. The rise in the prevalence of disorders and the ongoing demand for assay-related supplies are driving segment growth. Reagents are also consumables that are frequently employed in cell analysis tests, therefore demand is usually strong. These chemicals come in a variety of forms such as multicolor cocktails, probes, markers, and phenotyping agents. As a result, the adoption and acquisition of reagents result in market revenue generation. On the other hand, the instruments section generated money as a result of the installation of new instruments and the replacement of outdated ones. Automated instruments helped the market generate a sizable amount of income due to their high-end features and technically sophisticated analysis options.

By Technique, Flow cytometry held the highest market share in 2022. The significant market share represented by this segment is related to the high adoption of flow cytometry in single-cell analysis applications, which is attributed to its ability to measure multiple parameters in a heterogeneous sample at the single-cell level. In the contrast, the high-content screening segment is expected to grow at the fastest rate throughout the forecast period. The segment is growing due to an increase in the number of cell behavior studies. However, the complexities associated with cell image acquisition and analysis workflows owing to fluorescent illumination may hamper the segment's revenue generation ability to some extent.

By Process, cell identification had the highest market share in 2022. Cell identification is an important step in a variety of industrial applications, including food and healthcare. Cell identification is critical in drug discovery because cells are identified based on their reaction to a certain chemical. During the forecast period, the single-cell analysis sector is expected to grow at the fastest rate. Single-cell analysis has gained significant growth in recent years for assessing individual cells at a multi-parametric level, adding to the segment's growth.

By End User, The academic and research laboratories accounted for the highest revenue share of over 70.4% in 2022 owing to the wide use of single-cell analysis technology in research settings. The large number of current scientific research at various universities that use SCA methodologies has pushed its adoption until 2022. Another important factor boosting the industry is the development of spatial genomics, which speeds single-cell analysis in research operations. Furthermore, researchers at Stony Brook University in New York developed a brand-new biomedical research tool, single-cell cyclic multiplex in situ tagging (CycMIST) technology, in June 2022, which is driving the market. This approach allows scientists to evaluate functioning proteins in a single cell, which assists in diagnostic and discovery activities.
Cell Analysis Market Regional Insights
North America’s Cell Analysis System Market is expected to be leading due to the expansion of the biotechnology and pharmaceutical industries. The adoption of single-cell sequencing and increased cancer cell research is also expected to fuel the single-cell analysis system market. It is used in research and development to acquire important information by combining transcriptomics and genomes. The growth of biotechnological and biopharmaceutical companies is likely to provide opportunities in the Cell Analysis System Market. The strong research and development efforts, as well as the provision of government funds for accelerating development and improvements in cell analysis methods and instruments, have boosted the industry in recent decades. Companies and research organizations in these regions, for example, have been prominent players in doing significant research on stem cells and their application in curing life-threatening illnesses such as multiple sclerosis and cancer.

The Asia Pacific region is expected to witness significant growth at a CAGR of 12.1% through the forecast period. The primary drivers of regional growth include rapid growth of the pharmaceutical and biopharmaceutical market and reasonably priced cell analysis services. Manufacturers and academics are developing innovative methods to provide effective cell analysis systems that will aid in patient treatment. Additionally, manufacturers are concentrating on expanding their business in emerging nations, which is expected to drive the Cell Analysis System Market.The Cell Analysis Market report forecasts revenue growth at global, and country levels and provides an analysis of the latest industry trends in each of the sub-segments during the forecast period. MMR has segmented the global Cell Analysis Market report based on Product & Service, Technique, Process, End-User and region. The report contains strategic profiling of top key players in the market, a wide-ranging analysis of their core competencies, and their strategies like new product launches, growths, agreements, joint ventures, partnerships, and acquisitions that apply to the businesses. Our team of analysts can also provide you with data in excel files and pivot tables or can assist you in creating presentations from the data sets available in the report.
Cell Analysis Market Scope: Inquire before buying



Cell Analysis Market


Report Coverage
Details


Base Year:
2022
Forecast Period:
2023-2029


Historical Data:
2017 to 2022
Market Size in 2022:
US $ 18 Bn.


Forecast Period 2023 to 2029 CAGR:
10.5%
Market Size in 2029:
US $ 36.20 Bn.


 Segments Covered:
by Product & Service
• Reagents & Consumables
• Instruments
• Accessories
• Software
• Service


by Technique
• Flow Cytometry
• PCR
• Cell Microarrays
• Microscopy
• Spectrophotometry
• High Content Screening
• Other Techniques


by Process
• Cell Identification
• Cell Viability
• Cell Signaling Pathways/Signal Transduction
• Cell Proliferation
• Cell Counting and Quality Control
• Cell Interaction
• Cell Structure Study
• Target Identification and Validation
• Single-Cell Analysis


by End-User
• Pharmaceutical & Biotechnology Companies
• Hospitals and Clinical Testing Laboratories
• Academic and Research Institutes
• Other End Users



Cell Analysis Market, by Region
• North America (United States, Canada and Mexico)
• Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe)
• Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC)
• Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
• South America (Brazil, Argentina Rest of South America)
Cell Analysis Market, Key Players are:
• Thermo Fisher Inc.(US)
• Sigma-Aldrich Corporation(US)
• Terumo BCT(US)
• Promega Corporation(US)
• Bio-Rad Lab. Inc.(US)
• Becton(US)
• Dickinson & Company(US)
• Fluidigm Corporation(US)
• 10x Genomics, Inc.(US)
• Illumina Inc.(US)
• Merck Millipore(US)
• BD Biosciences(US)
• GE Healthcare(US)
• Miltenyi Biotec(Germany)
• QIAGEN NV (Germany)
• BGI(China)
• Novogene Corporation(China)

FAQs:

1. Who are the key players in the cell analysis market?
Ans. Some key players operating in the cell analysis market include Illumina, Inc., Thermo Fisher Scientific, Inc., Qiagen N.V., Bio-Rad Laboratories, Inc., Merck Millipore GmbH, Fluidigm, 10x Genomics, Inc., BGI, and Novogene Corporation.

2. Which product dominates the cell analysis market?
Ans. The consumables segment accounted for the largest share of the global cell analysis market in 2022. The growth of this segment is attributed to the increase in launches of affordable and cutting-edge consumables.

3. Which end-user segment of the global cell analysis market is expected to witness the highest growth??
Ans. The academic and research laboratories accounted for the highest revenue share of over 70.4% in 2022 owing to the wide use of single-cell analysis technology in research settings.

4. How big is the cell analysis market?
Ans. The total Cell Analysis Market was valued at USD 18 Billion in 2022 and is expected to reach USD 36.21 Billion by 2029 at a CAGR of 10.5% during the forecast period.

5. What is the impact of COVID-19 on the global cell analysis market?
Ans. The sudden outbreak of the COVID-19 pandemic has led to the adoption of cell analysis technology in research procedures for developing effective vaccines, drugs, and testing kits to combat the risk of coronavirus infection.

6. What are the key regions in the global cell analysis market?
Ans. Based On the region, the market has been classified into North America, Europe, Asia Pacific, Middle, East and Africa, and Latin America. North America dominates the global market.